Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?

被引：1
|
作者：
Buckman, Robert [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada
来源：
BREAST | 2011年 / 20卷 / 05期
关键词：
D O I：
10.1016/j.breast.2011.06.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [21] Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
    Khan, O. A.
    Blann, A. D.
    Payne, M. J.
    Middleton, M. R.
    Protheroe, A. S.
    Talbot, D. C.
    Taylor, M.
    Han, C.
    Patil, M.
    Harris, A. L.
    BRITISH JOURNAL OF CANCER, 2011, 104 (12) : 1822 - 1827
  • [22] Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
    O A Khan
    A D Blann
    M J Payne
    M R Middleton
    A S Protheroe
    D C Talbot
    M Taylor
    C Han
    M Patil
    A L Harris
    British Journal of Cancer, 2011, 104 : 1822 - 1827
  • [23] Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
    Emmenegger, Urban
    Francia, Giulio
    Chow, Annabelle
    Shaked, Yuval
    Kouri, Andrew
    Man, Shan
    Kerbel, Robert S.
    NEOPLASIA, 2011, 13 (01): : 40 - 48
  • [24] Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
    Isono-Nakata, Rose
    Tsubamoto, Hiroshi
    Ueda, Tomoko
    Inoue, Kayo
    Shibahara, Hiroaki
    GYNECOLOGIC ONCOLOGY REPORTS, 2018, 24 : 57 - 60
  • [25] The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells
    Krajnak, Slavomir
    Loewe, Amelie
    Battista, Marco Johannes
    Hasenburg, Annette
    Heimes, Anne-Sophie
    Schmidt, Marcus
    Schwab, Roxana
    Brenner, Walburgis
    ANTICANCER RESEARCH, 2021, 41 (03) : 1243 - 1250
  • [26] LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LOW-DOSE CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
    SPICER, DV
    KELLEY, A
    HERMAN, R
    DEAN, G
    STEVENSON, L
    MITCHELL, MS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (06) : 424 - 426
  • [27] Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: A well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia
    Emmenegger, U
    Morton, GC
    Francia, G
    Shaked, Y
    Franco, M
    Weinerman, A
    Man, S
    Kerbel, RS
    CANCER RESEARCH, 2006, 66 (03) : 1664 - 1674
  • [28] Efficacy of low-dose capecitabine in metastatic breast cancer
    Bertelsen, Caitlin
    Ji, Lingyun
    Russell, Christy Ann
    Spicer, Darcy V.
    Garcia, Agustin
    Sposto, Richard
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] A Retrospective Analysis of the Efficacy of Low-Dose Metronomic Cyclophosphamide for Treatment in Patients with Low Grade Non-Hodgkin Lymphoma
    Han, Boram
    Kim, Bum Jun
    Kim, Ho Young
    Zang, Dae Young
    Lim, Hyun
    Kang, Ho Suk
    Soh, Jae Seung
    Kim, Hyo Jung
    BLOOD, 2021, 138
  • [30] Low-dose metronomic cyclophosphamide/methotrexate (LDCM) and aspirin for patients without pathologic complete response (pCR) after neoadjuvant treatment for stage II-III breast cancer
    Burdette-Radoux, Susan
    Holmes, Chris E.
    Khan, Farrah B.
    Dittus, Kim
    Wilson, Karen M.
    Wood, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
12345